Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by MYSTICALon May 19, 2015 1:34pm
330 Views
Post# 23741470

Can anybody put it together ?

Can anybody put it together ?
May 19, 2015 PROMETIC ENTERS INTO STRATEGIC LONG-TERM MANUFACTURING AGREEMENT WITH EMERGENT BIOSOLUTIONS May 8, 2015 ProMetic Life Sciences Given New C$3.25 Price May 7, 2015 PROMETIC TO DEVELOP C1 ESTERASE INHIBITOR (C1-INH) AS ITS NEXT PLASMA-DERIVED DRUG CANDIDATE April 14, 2015 PROMETIC ANNOUNCES $50 MILLION BOUGHT DEAL OFFERING TO FUND STRATEGIC GROWTH INITIATIVES March 19,2015 ProMetic Successfully Completes Its PBI-4050 Phase Ib in Patients With Chronic Kidney Disease ("CKD") March 16,2015 ProMetic Announces Its Inclusion to the S&P/TSX Composite Index
Bullboard Posts